A viral clonality evenness score to predict progression to adult T-cell leukaemia in asymptomatic carriers of human T-lymphotropic virus type 1 in Japan: a retrospective longitudinal cohort study
The Lancet Microbe · 2025
DOI: 10.1016/j.lanmic.2025.101198 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Lancet Microbe, 2025. Verfasst von Snehal Dilip Karpe und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Viral Oncogenesis, Institut Jules Bordet-HUB, ULB, Brussels, Belgium; Unit of Animal Genomics, GIGA, ULiège, Liège, Belgium. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections, Carrier State. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Association Jules Bordet, Japan Society for the Promotion of Science, Fonds Léon Fredericq.
Abstract (Originalsprache)
BACKGROUND: Adult T-cell leukaemia/lymphoma (ATL) is a highly aggressive T-cell malignancy that occurs in approximately 2-7% of individuals with human T-lymphotropic virus type 1 (HTLV-1), after decades of asymptomatic infection. To address the urgent need for predictive biomarkers to identify asymptomatic carriers of HTLV-1 at high risk of progression to ATL, we aimed to evaluate viral clonality sequencing as a potential tool for risk stratification. METHODS: This retrospective longitudinal cohort study involved HTLV-1 carriers enrolled in the Joint Study on Predisposing Factors of ATL Development, a nationwide cohort study initiated in Japan in 2002. Participants were selected from this cohort on the basis of their baseline proviral load at the time of enrolment as an asymptomatic carrier, length of follow-up, and clinical outcome. The cohort was subdivided into three subgroups: the first comprising HTLV-1 carriers who developed ATL, the second comprising carriers with high proviral load (≥4%) who did not progress to ATL, and the third comprising carriers with low proviral load (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Viral Oncogenesis, Institut Jules Bordet-HUB, ULB, Brussels, Belgium; Unit of Animal Genomics, GIGA, ULiège, Liège, Belgium.
- Unit of Animal Genomics, GIGA, ULiège, Liège, Belgium.
- Laboratory of Tumor Cell Biology, The University of Tokyo, Tokyo, Japan.
- Department of Hematology, Sasebo City General Hospital, Nagasaki, Japan.
- Clinical Epidemiology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Förderung
- Association Jules Bordet
- Japan Society for the Promotion of Science
- Fonds Léon Fredericq
- Fund for Scientific Research
- Fondation contre le Cancer
Zitieren
APA
Karpe, S. D., Artesi, M., Wayet, J., Durkin, K., Hahaut, V., Uchimaru, K., Makiyama, J., Iwanaga, M., Utsunomiya, A., Kolijn, P. M., Langerak, A. W., Burny, A., Marçais, A., Hermine, O., Watanabe, T., Georges, M., & Van den Broeke, A. (2025). A viral clonality evenness score to predict progression to adult T-cell leukaemia in asymptomatic carriers of human T-lymphotropic virus type 1 in Japan: a retrospective longitudinal cohort study. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2025.101198
Vancouver
Karpe SD, Artesi M, Wayet J, Durkin K, Hahaut V, Uchimaru K, et al. A viral clonality evenness score to predict progression to adult T-cell leukaemia in asymptomatic carriers of human T-lymphotropic virus type 1 in Japan: a retrospective longitudinal cohort study. The Lancet Microbe. 2025. doi:10.1016/j.lanmic.2025.101198
BibTeX
@article{Karpe2025,
author = {Karpe, Snehal Dilip and Artesi, Maria and Wayet, Jérôme and Durkin, Keith and Hahaut, Vincent and Uchimaru, Kaoru and Makiyama, Junya and Iwanaga, Masako and Utsunomiya, Atae and Kolijn, P Martijn and Langerak, Anton W and Burny, Arsène and Marçais, Ambroise and Hermine, Olivier and Watanabe, Toshiki and Georges, Michel and Van den Broeke, Anne},
title = {A viral clonality evenness score to predict progression to adult T-cell leukaemia in asymptomatic carriers of human T-lymphotropic virus type 1 in Japan: a retrospective longitudinal cohort study},
journal = {The Lancet Microbe},
year = {2025},
doi = {10.1016/j.lanmic.2025.101198}
}
EUVIMED